echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Yiling Pharmaceutical: Azithromycin tablets passed the consistency evaluation of generic drugs

    Yiling Pharmaceutical: Azithromycin tablets passed the consistency evaluation of generic drugs

    • Last Update: 2021-08-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On August 9, Yiling Pharmaceutical issued an announcement stating that the company had received the Approval Notice for Supplementary Drug Application for Azithromycin tablets approved and issued by the State Food and Drug Administration.


    Azithromycin is a semi-synthetic 15-membered macrolide antibiotic, which is a commonly used macrolide antibiotic in clinical practice


    Acute onset of chronic bronchitis bacterial infection caused by Haemophilus influenzae, Moraxella catarrhalis or Streptococcus pneumoniae


    Azithromycin tablets are a category A variety of the National Medical Insurance Catalog (2020 edition) and a variety of the National Essential Medicines Catalog (2018 edition)


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.